Breaking News Instant updates and real-time market news.

ABMD

Abiomed

$394.49

0.04 (0.01%)

, WYN

Wyndham

$107.98

-0.58 (-0.53%)

17:21
05/25/18
05/25
17:21
05/25/18
17:21

ABIOMED to replace Wyndham in the S&P 500 at open on May 31st

ABMD

Abiomed

$394.49

0.04 (0.01%)

WYN

Wyndham

$107.98

-0.58 (-0.53%)

  • 30

    May

  • 05

    Jun

  • 12

    Jun

ABMD Abiomed
$394.49

0.04 (0.01%)

02/22/18
PIPR
02/22/18
NO CHANGE
Target $300
PIPR
Overweight
Piper sees 'so much to like' at Abiomed, recommends buying shares
After hosting investor meetings with Abiomed management, Piper Jaffray analyst Matt O'Brien says "there is so much to like here." Management noted that the label expansions from last week were likely to expand the shock patient population by 20%-25%, O'Brien tells investors in a research note. He sees "significant room for growth" from Impella and keeps an Overweight rating on Abiomed shares with a $300 price target. The analyst continues to encourage investors to start or build positions.
04/04/18
GSCO
04/04/18
INITIATION
Target $332
GSCO
Buy
Abiomed initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Issac Ro started Abiomed with a Buy rating and $332 price target.
04/25/18
PIPR
04/25/18
NO CHANGE
PIPR
Overweight
Piper says IPPS rates appear negative, but are really neutral for Abiomed
After Abiomed issued an 8k discussing the Centers for Medicare and Medicaid Services' proposed Inpatient Prospective Payment System, or IPPS, rates for Impella, Piper Jaffray analyst Matt O'Brien said the rates look negative "at first blush." However, when considering that very few Impella cases are billed to the DRG code for which the CMS proposed a cut of 24%, he said he views the proposed IPPS as "fairly neutral" for Abiomed. Adding that the code where most Impella cases are performed is proposed to be up about 3% in the current rule, O'Brien said he would take advantage of any weakness to start or build Abiomed positions. He keeps an Overweight rating on the shares.
05/03/18
PIPR
05/03/18
NO CHANGE
Target $360
PIPR
Overweight
Abiomed price target raised to $360 from $300 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target for Abiomed to $360 saying this morning's Q4 results easily beat his estimates. The momentum in using Impella to treat patients "remains strong" and there are new products and geographies that should continue to drive sales, O'Brien tells investors in a post-earnings research note. The analyst, while admitting the valuation is "hefty," reiterates an Overweight rating on Abiomed. He continues to encourage investors to own the name.
WYN Wyndham
$107.98

-0.58 (-0.53%)

03/23/18
STFL
03/23/18
NO CHANGE
Target $135
STFL
Buy
Wyndham shares have more room to run, says Stifel at Stifel
Stifel analyst Simon Yarmak took a deep dive into Wyndham Worldwide's Form 10 for the previously announced spin-off of Wyndham Hotels & Resorts, which is expected in Q2. In a research note to investors, Yarmak, who has a Buy rating and $135 price target on shares, said shares have had a "good" run, with shares up 21.3% vs. the S&P since the spin was announced in August, and sees more room for shares to run. He sees upside heading into the spinoff.
04/02/18
OPCO
04/02/18
INITIATION
Target $135
OPCO
Outperform
Wyndham initiated with an Outperform at Oppenheimer
Oppenheimer analyst Ian Zaffino started Wyndham Worldwide (WYN) with an Outperform rating and $135 price target, calling the company the leader in the economy/upper-economy hotel space and saying he believes the planned acquisition of La Quinta (LQ) will also make it the leader in the premier midscale segment.
05/07/18
STFL
05/07/18
NO CHANGE
Target $131
STFL
Buy
Wyndham selloff after earnings overdone, says Stifel
Stifel analyst Simon Yarmak said Wyndham's (WYN) Q1 earnings release was a headline beat and he viewed the incremental information as largely positive, stating that he sees the selloff since as being overdone and recommends buying the shares ahead of the spinoff. While the Marriott Vacations (VAC) and ILG (ILG) deal may have disappointed some investors with respect to synergies, the acquisition price should have a positive read-through to Wyndham, added Yarmak. He lowered his price target on Wyndham to $131 from $135 and keeps a Buy rating on the shares.
05/18/18
FBCO
05/18/18
INITIATION
Target $116
FBCO
Neutral
Wyndham initiated with a Neutral at Credit Suisse
Credit Suisse analyst Cameron McKnight started Wyndham with a Neutral rating and $116 price target, stating in a note to investors sent earlier this morning that while he is positive on the timeshare space, he sees a mix of fundamental positives and challenges for Wyndham, the largest timeshare company which will shortly spin off its hotel business.

TODAY'S FREE FLY STORIES

BHP

BHP Billiton

$47.63

-1.34 (-2.74%)

21:07
06/19/18
06/19
21:07
06/19/18
21:07
Periodicals
BHP to sell Cerro Colorado copper mine to EMR Capital for $230M, Reuters says »

BHP has reached an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALA

Kala Pharmaceuticals

$13.38

-0.36 (-2.62%)

21:04
06/19/18
06/19
21:04
06/19/18
21:04
Recommendations
Kala Pharmaceuticals analyst commentary  »

Kala Pharma's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

CAFD

8point3 Energy

$12.42

0.01 (0.08%)

20:21
06/19/18
06/19
20:21
06/19/18
20:21
Hot Stocks
8point3 Energy closes merger transaction »

8point3 Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$46.29

-0.25 (-0.54%)

20:15
06/19/18
06/19
20:15
06/19/18
20:15
Recommendations
Oracle analyst commentary  »

Oracle cloud business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

TLSYY

Telstra

$0.00

(0.00%)

20:01
06/19/18
06/19
20:01
06/19/18
20:01
Hot Stocks
Telstra sees FY19 EBITDA $8.7B-$9.4B »

To cut 8,000 staff and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXC

Exelon

$41.61

-0.11 (-0.26%)

, FSLR

First Solar

$52.21

0.39 (0.75%)

19:52
06/19/18
06/19
19:52
06/19/18
19:52
Periodicals
First Solar, Exelon push for carbon tax legislation, Bloomberg reports »

Exelon (EXC) has…

EXC

Exelon

$41.61

-0.11 (-0.26%)

FSLR

First Solar

$52.21

0.39 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLXN

Flexion

$27.40

0.63 (2.35%)

, ANIK

Anika Therapeutics

$45.99

0.9 (2.00%)

19:21
06/19/18
06/19
19:21
06/19/18
19:21
Recommendations
Flexion, Anika Therapeutics analyst commentary at Wells Fargo »

Flexion to benefit from…

FLXN

Flexion

$27.40

0.63 (2.35%)

ANIK

Anika Therapeutics

$45.99

0.9 (2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

ENSG

Ensign Group

$38.55

0.06 (0.16%)

19:07
06/19/18
06/19
19:07
06/19/18
19:07
Hot Stocks
Ensign Group subsidiary acquires office building in San Juan Capistrano »

The Ensign Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNOV

MediciNova

$8.37

-0.03 (-0.36%)

19:01
06/19/18
06/19
19:01
06/19/18
19:01
Hot Stocks
MediciNova receives Notice of Allowance from JPO for new patent covering MN-001 »

MediciNova announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAESY

BAE Systems

$0.00

(0.00%)

19:00
06/19/18
06/19
19:00
06/19/18
19:00
Hot Stocks
USMC awards BAE Systems $198M amphibious combat vehicle contract »

The U.S. Marine Corps has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$228.20

-3.185 (-1.38%)

18:59
06/19/18
06/19
18:59
06/19/18
18:59
Periodicals
Goldman plans to invest $500M in women-run companies, Reuters says »

Goldman Sachs intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

NTIP

Network-1 Technologies

$3.00

(0.00%)

, SYNA

Synaptics

$48.81

-0.35 (-0.71%)

18:50
06/19/18
06/19
18:50
06/19/18
18:50
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Network-1…

NTIP

Network-1 Technologies

$3.00

(0.00%)

SYNA

Synaptics

$48.81

-0.35 (-0.71%)

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

PRTA

Prothena

$14.99

0.43 (2.95%)

LZB

La-Z-Boy

$33.25

0.1 (0.30%)

ORCL

Oracle

$46.29

-0.25 (-0.54%)

FDX

FedEx

$258.35

-5.295 (-2.01%)

ANIK

Anika Therapeutics

$45.99

0.9 (2.00%)

KIN

Kindred Biosciences

$10.00

-0.55 (-5.21%)

SBUX

Starbucks

$57.43

0.22 (0.38%)

GE

General Electric

$12.96

-0.24 (-1.82%)

VALE

Vale

$12.97

-0.21 (-1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 19

    Jun

  • 19

    Jun

  • 22

    Jun

  • 28

    Jun

  • 09

    Jul

  • 10

    Jul

  • 12

    Jul

  • 20

    Sep

  • 21

    Sep

  • 20

    Jun

SD

SandRidge Energy

$17.03

1.21 (7.65%)

, IEP

Icahn Enterprises

$72.11

-0.62 (-0.85%)

18:44
06/19/18
06/19
18:44
06/19/18
18:44
Hot Stocks
SandRidge Energy reaches pact with Icahn Capital on board composition »

SandRidge Energy (SD)…

SD

SandRidge Energy

$17.03

1.21 (7.65%)

IEP

Icahn Enterprises

$72.11

-0.62 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$106.20

-0.85 (-0.79%)

18:32
06/19/18
06/19
18:32
06/19/18
18:32
Hot Stocks
Disney names Jennifer lee Walt Disney Animation Studios CCO »

Disney announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRIL

Trillium Therapeutics

$6.20

0.05 (0.81%)

18:32
06/19/18
06/19
18:32
06/19/18
18:32
Syndicate
Trillium Therapeutics announces 'at-the-market' issuance program »

Trillium Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$32.39

0.19 (0.59%)

, GOOG

Alphabet

$1,167.86

-5.77 (-0.49%)

18:17
06/19/18
06/19
18:17
06/19/18
18:17
Periodicals
AT&T in discussions to purchase AppNexus, Cheddar reports »

AT&T (T) is in talks…

T

AT&T

$32.39

0.19 (0.59%)

GOOG

Alphabet

$1,167.86

-5.77 (-0.49%)

GOOGL

Alphabet Class A

$1,178.29

-5.69 (-0.48%)

FB

Facebook

$197.46

-0.84 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Oct

AAL

American Airlines

$41.51

-0.93 (-2.19%)

18:14
06/19/18
06/19
18:14
06/19/18
18:14
Periodicals
Breaking Periodicals news story on American Airlines »

American Airlines offers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

ZN

Zion Oil & Gas

$3.13

(0.00%)

18:13
06/19/18
06/19
18:13
06/19/18
18:13
Hot Stocks
Zion Oil & Gas to start operations at Megiddo-Jezreel #1 as soon as June 21 »

Zion Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.43

0.22 (0.38%)

18:10
06/19/18
06/19
18:10
06/19/18
18:10
Hot Stocks
Starbucks says China third party delivery 'was not a good experience' »

Comments taken from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 22

    Jun

EQH

AXA Equitable

$20.94

-0.01 (-0.05%)

18:07
06/19/18
06/19
18:07
06/19/18
18:07
Hot Stocks
Breaking Hot Stocks news story on AXA Equitable »

AXA Equitable reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

EQH

AXA Equitable

$20.94

-0.01 (-0.05%)

18:06
06/19/18
06/19
18:06
06/19/18
18:06
Earnings
AXA Equitable reports Q1 non-GAAP EPS 83c, consensus 82c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

BAESY

BAE Systems

$0.00

(0.00%)

18:06
06/19/18
06/19
18:06
06/19/18
18:06
Periodicals
USMC awards BAE contract to deliver new amphibious vehicles, Reuters says »

The U.S. Marine Corp has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNI

ATN International

$55.30

0.57 (1.04%)

18:04
06/19/18
06/19
18:04
06/19/18
18:04
Hot Stocks
ATN International acquires Geoverse LLC, terms not disclosed »

Geoverse, LLC, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

, GE

General Electric

$12.96

-0.24 (-1.82%)

18:01
06/19/18
06/19
18:01
06/19/18
18:01
Hot Stocks
Walgreens Boots Alliance to replace General Electric in DJIA at open on 6/26 »

Walgreens Boots Alliance…

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

GE

General Electric

$12.96

-0.24 (-1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

HPE

HP Enterprise

$15.90

-0.02 (-0.13%)

18:01
06/19/18
06/19
18:01
06/19/18
18:01
Hot Stocks
HP Enterprise to invest $4B in Intelligent Edge technologies »

Hewlett Packard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.